The hospitalist services provider has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
IPCM currently has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the same sector include Envision Healthcare Holdings, Inc. (EVHC), BG Medicine, Inc. (BGMD) and Charles River Laboratories International, Inc. (CRL). While Envision Healthcare sports a Zacks Rank #1 (Strong Buy), BG Medicine and Charles River hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment